| ||
| Peregrine says lung cancer drug extended survival CNBC.com The results come from a mid-stage study of 49 patients with untreated, advanced non-small cell lung cancer. In addition to bavituximab, Peregrine said the patients were treated with the chemotherapy drugs carboplatin and paclitaxel. ... See all stories on this topic » |
| ||
| Dr. Jon LaPook: Laura Ziskin: Remembering A Pioneer In Fighting Cancer By Dr. Jon LaPook An example is the rapid development of a new type of lung cancer treatment by scientists in California and Maryland. Last September, we profiled that stunning teamwork in a segment that aired on the "CBS Evening News" the night of the ... Health on Huffington Post |
| ||
| Targeted lung cancer therapy using ephrinA1-loaded albumin ... Lee, H.-Y., Mohammed, K. A., Peruvemba, S., Goldberg, E. P. and Nasreen, N. ( 2011), Targeted lung cancer therapy using ephrinA1-loaded albumin microspheres. ... onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.../abstract | ||
| MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Our results demonstrated that cationic lipoplexes are a promising carrier system for the development of miRNA-based therapeutics in lung cancer treatment. ... www.ncbi.nlm.nih.gov/pubmed/21648427 |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment